American Academy of Neurology; FAHN, S. 1998. Tolcapone: COMT [Catechol O-methyltransferase] inhibition for the treatment of Parkinson's disease. Hagerstown: Lippincott-Raven Publishers.
APA (7th ed.) CitationAmerican Academy of Neurology & Fahn, S. (1998). Tolcapone: COMT [Catechol O-methyltransferase] inhibition for the treatment of Parkinson's disease. Lippincott-Raven Publishers.
Chicago Style (17th ed.) CitationAmerican Academy of Neurology and Stanley Fahn. Tolcapone: COMT [Catechol O-methyltransferase] Inhibition for the Treatment of Parkinson's Disease. Hagerstown: Lippincott-Raven Publishers, 1998.
MLA (9th ed.) CitationAmerican Academy of Neurology and Stanley Fahn. Tolcapone: COMT [Catechol O-methyltransferase] Inhibition for the Treatment of Parkinson's Disease. Lippincott-Raven Publishers, 1998.
